Looking into the future with bioresorbable vascular scaffolds
- 1 October 2013
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Review of Cardiovascular Therapy
- Vol. 11 (10), 1407-1416
- https://doi.org/10.1586/14779072.2013.839200
Abstract
Bioresorbable scaffold technology has evolved over the last few years with a number of devices either available or under clinical and preclinical investigation. The absence of a permanent metallic segment in the treated vessel wall has the potential to address some of the issues still encountered with metallic drug-eluting stents despite improvements in stent platform, polymer and drug elution. Here, the authors review currently available bioresorbable scaffolds for coronary artery use, concentrating on both completed and ongoing preclinical and clinical studies, evaluating their use. The authors also discuss the potential advantages as well as challenges that these novel devices may face in routine clinical practice.Keywords
This publication has 14 references indexed in Scilit:
- Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trialHeart, 2012
- Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis: 12-Month Clinical and Imaging OutcomesJournal of the American College of Cardiology, 2011
- OrbusNeich fully absorbable coronary stent platform incorporating dual partitioned coatingsEuroIntervention, 2009
- A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methodsThe Lancet, 2009
- Late Stent Recoil of the Bioabsorbable Everolimus-Eluting Coronary Stent and its Relationship With Plaque MorphologyJournal of the American College of Cardiology, 2008
- A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trialThe Lancet, 2008
- Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trialThe Lancet, 2007
- Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting StentCirculation, 2004
- Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology?Heart, 2003
- Initial and 6-Month Results of Biodegradable Poly- l -Lactic Acid Coronary Stents in HumansCirculation, 2000